Page last updated: 2024-11-01

ondansetron and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

ondansetron has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.

Research Excerpts

ExcerptRelevanceReference
"Ondansetron is a commonly used medication in the treatment of nausea and vomiting arising from many etiologies, including chemotherapy."7.74Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL. ( Pinsk, M; Turner, SR, 2008)
"Ondansetron is a commonly used medication in the treatment of nausea and vomiting arising from many etiologies, including chemotherapy."3.74Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL. ( Pinsk, M; Turner, SR, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghafouri, N1
Darracq, MA1
Cantrell, FL1
Turner, SR1
Pinsk, M1

Other Studies

2 other studies available for ondansetron and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Ondansetron-associated hypotension following pediatric self-poisoning.
    Pediatric emergency care, 2012, Volume: 28, Issue:6

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Overdose; Emergencies; Huma

2012
Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:1

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cytarab

2008